Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Welcome to Wales.
If you’re thinking about where to locate your Life Sciences business, browsing these pages will give you a glimpse of what you can expect of us and of Wales.
Welcome to Wales.
If you’re thinking about where to locate your Life Sciences business, browsing these pages will give you a glimpse of what you can expect of us and of Wales.
The Collections Trust is piloting a new concept called 'Investors in Collections'. Designed to be compatible with the UK Museum Accreditation Scheme and the American Alliance of Museums 'Continuum of Excellence', Investors in Collections provides a way for museums to demonstrate their commitment to achieving excellence in their Collections Management.
This presentation is all about the NHS and is useful to use with students who do not know much about the UK and are interested in travelling there. Some of the information you may need to check and update, as some things are changing in the UK and may have changed since I made it.
Building cross-sectoral partnerships to foster the support to entrepreneurship might well be context dependent, needs to be built on its own, regional strengths, and taken actions need to be focussed.
Update and forward plan for ENUMERATE - Digitisation intelligence for EuropeNicholas Poole
Presentation to the European Member States Expert Group on digitisation, digital preservation and online access to cultural heritage, looking at the outcomes and next steps with the ENUMERATE project to create intelligence about digitisation for Europe.
CT/ACE Collections Management Traineeship ProgrammeNicholas Poole
An introduction to the joint Arts Council England/Collections Trust Collections Management Traineeship Programme for employers and prospective candidates.
The HR Strategy as a driver for excellence - DRC annual meeting 2010, Novi Sa...Dagmar M. Meyer
Presentation given at the 26th Annual Meeting of the Danube Rectors' Conference which took place on 4-6 February 2010 in Novi Sad.
For more details on the meeting see http://www.drc.uns.ac.rs/index.html.
Dr Liz Mear, Chief Executive of the Innovation Agency presented at NHS Confed 17 about the NHS’ role in growing local economies and how Academic Health and Science Networks (AHSNs) can generate economic growth in life sciences through their role as catalysts, connectors and collaborators by spreading innovation, advancing health technology and improving healthcare
The Collections Trust is piloting a new concept called 'Investors in Collections'. Designed to be compatible with the UK Museum Accreditation Scheme and the American Alliance of Museums 'Continuum of Excellence', Investors in Collections provides a way for museums to demonstrate their commitment to achieving excellence in their Collections Management.
This presentation is all about the NHS and is useful to use with students who do not know much about the UK and are interested in travelling there. Some of the information you may need to check and update, as some things are changing in the UK and may have changed since I made it.
Building cross-sectoral partnerships to foster the support to entrepreneurship might well be context dependent, needs to be built on its own, regional strengths, and taken actions need to be focussed.
Update and forward plan for ENUMERATE - Digitisation intelligence for EuropeNicholas Poole
Presentation to the European Member States Expert Group on digitisation, digital preservation and online access to cultural heritage, looking at the outcomes and next steps with the ENUMERATE project to create intelligence about digitisation for Europe.
CT/ACE Collections Management Traineeship ProgrammeNicholas Poole
An introduction to the joint Arts Council England/Collections Trust Collections Management Traineeship Programme for employers and prospective candidates.
The HR Strategy as a driver for excellence - DRC annual meeting 2010, Novi Sa...Dagmar M. Meyer
Presentation given at the 26th Annual Meeting of the Danube Rectors' Conference which took place on 4-6 February 2010 in Novi Sad.
For more details on the meeting see http://www.drc.uns.ac.rs/index.html.
Dr Liz Mear, Chief Executive of the Innovation Agency presented at NHS Confed 17 about the NHS’ role in growing local economies and how Academic Health and Science Networks (AHSNs) can generate economic growth in life sciences through their role as catalysts, connectors and collaborators by spreading innovation, advancing health technology and improving healthcare
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Academic Health Science Networks supporting strategic commissioningInnovation Agency
Dr Liz Mear, Chief Executive of the Innovation Agency, presented at NHS Confed 17 on Academic Health Science Networks (AHSNs) supporting strategic commissioning and bringing innovators, commissioners, clinicians and patients to together to develop closer collaboration and a demonstrably clearer understanding of NHS needs and opportunities.
Let us share with you our successes, impacts and performance over the past year. The Innovation Agency is proud to bring you our Annual Report for 2015/16.
Mobilising Evidence and Organisational Knowledge in the NHSCILIP
Sue Lacey Bryant (Senior Advisor, Knowledge for Healthcare, Health Education England) and Louise Goswami's (Head of Library and Knowledge Services Development, Health Education England) presentation to the CILIP 2017 Conference in Manchester #CILIPConf17
Health Education England (HEE) is driving the implementation of Knowledge for Healthcare which articulates an ambitious vision for healthcare library and knowledge services funded by the NHS. These services supply the evidence base to the NHS to make #AMillionDecisions a day. HEE is taking a strategic approach to mobilising evidence and organisational knowledge through policy and advocacy initiatives, by introducing new resources, tools and techniques and by empowering our workforce. Partnership working across all sectors, and including CILIP, is central to our success. The speakers will outline their approach, share experience and invite ongoing dialogue.
Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
Presentation by Lorna Green, Chief Operating Officer, Innovation Agency: Health innovation funding and collaboration opportunities at the International Business Festival 2018, 26 June, Exhibition Centre Liverpool
Presentation by Andrew Cooper, Associate Director Patient Safety, Innovation Agency, at the Emergency Laparotomy Collaborative event on Monday, 17 June at The Foresight Centre, Liverpool.
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
UK Trade & Investment busca estudiantes de último año y titulados emprendedores y con talento de todo el mundo para apoyarles en el enorme potencial que ofrece el entorno de Reino Unido para el establecimiento y crecimiento de sus empresas
UK Trade & Investment busca estudiantes de último año y titulados emprendedores y con talento de todo el mundo para apoyarles en el enorme potencial que ofrece el entorno de Reino Unido para el establecimiento y crecimiento de sus empresas
UK Trade & Investment busca estudiantes de último año y titulados emprendedores y con talento de todo el mundo para apoyarles en el enorme potencial que ofrece el entorno de Reino Unido para el establecimiento y crecimiento de sus empresas
Centro mundial de excelencia para la innovación en el ámbito urbano. Un lugar en el que ciudades, negocios y universidades se reúnen para crear soluciones dirigidas a cubrir las necesidades futuras de las ciudades del Reino Unido.
UK Trade & Investment está buscando a estudiantes de último año y titulados con talento de todo el mundo para que aprovechen el enorme potencial que ofrece el entorno de Reino Unido para el establecimiento de empresas y apoyo a su crecimiento.
Spain holds the 9th largest accumulated inward FDI stock and the 11th largest investor in the world. It offers many business opportunities and investment in many sectors as: Information and Communication Technologies (ICT), Environmental, Biotechnology, Aerospace, Automotive, Logistics & Transport and Renewable Energies.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
2. • Population of over 3 million
• Devolved Government with a First Minister, Cabinet
and electedAssembly
• £15bn budget
• Responsible areas include Health, Education,
Transport and Economic Development
• Two hours from Central London
• Our own language and a distinct culture
• Diverse geography and a fantastic quality of life !
Wales
3. Invest in Wales
• NHS Wales is the publically funded National Health Service of Wales providing healthcare to some 3 million
people who live in the county.
• 70,000 people are directly employed by NHS Wales – making the health service Wales’s largest employer.
• The Welsh Government invests £6bn a year, or 40% of its budget in health and social services.
• NHS Wales delivers healthcare services through 7 Local Health Boards (LHBs) and 3 NHS Trusts.
• Much of the £6bn funding is directly allocated to the Local Health Boards and Trusts.
• There are 122 Hospitals in Wales.
• 676 GP Surgeries.
NHS Wales …
4. Invest in Wales
• NHS Wales Informatics Service (NWIS) is a national organisation providing the information and
technology services used by NHS Wales to support high quality patient care.
• Their work covers the development of new national products and the delivery of operational
technology and information services.
• All products and services are developed in collaboration with health boards and health professionals
in NHS Wales, to meet the needs of NHS Wales now and in the future.
NHS Wales Informatics Service (NWIS) …
5. Invest in Wales
• Procurement Services is part of the NHS Shared Services Partnership (NWSSP)
• The role of the Procurement Services is to provide Sourcing, Supply Chain and Purchasing support
to the Local Health Boards and Trusts across Wales.
• www.procurement.wales.nhs.uk
NHS Wales Procurement Services …
7. Life Sciences Wales
The Research Universities
• Major strengths in fundamental research and translation
• Stem cells – Prof Martin Evans
• Neuroscience – Sir Mike Owen
• Clinical research and translation – Institute of Life Science
• Ser Cymru – “Science stars” - £50m
• National Research Network - £7.3m
Connecting. Inspiring. Accelerating Growth
8. Life Sciences Hub Wales
The Hub
• A central resource for Wales
• Includes Universities, Business, NHS, Welsh Government,
Professional services, Funding
• Stimulate interaction, innovation, networking and collaboration
• Attract new opportunities for investment by raising international
reputation of Wales
• Accelerate the growth of the sector by sourcing and brokering
opportunities
• Centre for meetings, events, seminars, visits
Connecting. Inspiring. Accelerating Growth
9. Invest in Wales
Life Sciences
Invest in Wales
Cardiff Medicentre – Cardiff
• Dedicated Medical, Healthcare and Life Sciences business incubator
• Located on the University Hospital of Wales campus along with Cardiff
University's School of Medicine
• Provides dedicated business incubation facilities for start-up and spin-
out companies in the Medical, Healthcare and Life Sciences sectors
Start-up & Spin-out Support …
The Institute of Life Science (ILS), Swansea University
• ILS1 – state-of-the-art building, housing specialists in medical research,
business incubation and technology transfer, strategically located
between the College of Medicine and Singleton Hospital.
• ILSII – provides an extended range of fully operational business
incubation units, a clinical research facility, imaging suite and Centre
for NanoHealth.
10. Welsh Wound Innovation Centre
• £4million national centre of excellence in wound prevention and treatment
consolidates and maximises the expertise in Wales for wound care
• Led by Professor Keith Harding CBE,
• All 7 Health Boards and Welsh Government joint commitment for an all-
Wales project, which is explicitly industry-facing
• Full range of clinical and research services to commercial customers under
one roof (National Wound Registry , business incubation, contract
education, contract research and clinical services)
• Development of associated business cluster and cements Wales’s global
reputation for innovation in wound care
12. • Healthcare innovation officials are developing an NHS Wales industry engagement framework to allow
Health Boards to engage with industry in a way that ensures alignment with health strategic objectives
and prudent healthcare in an open and transparent way.
• A stakeholder reference group with senior clinical, academic and government representatives will meet
in the Spring to draw upon the experience of each partnership and to ensure that first principles are
drafted from a Welsh/Public value perspective and informed by real world understanding of industry
collaboration.
• Healthcare innovation officials are currently undertaking an engagement exercise to map out and
understand what prudent innovation and existing industry engagement arrangements are currently in
place across NHS Wales.
Industry Engagement
13. Health Technology and Telehealth Fund
• The projects supported by the Health Technology and Telehealth Fund have now reached the end of
their third quarter of delivery with the majority reporting good progress.
• A HTTF Network has been developed made up of the project teams and Innovation leads. The
purpose of the network is to share best practice and encourage the wider roll out of projects where
possible..
• Work is ongoing with ES&T colleagues on an exercise to map NHS Wales current procurement
activity against what it possible within Welsh markets to establish how the NHS can further support
the Welsh Economy within procurement regulation.
14. BioWales 2015
Bespoke sessions on Selling to the NHS with an NHS
Director of Finance, Director of Procurement and Medical
Director.
BioWales Video